Pulmonary Screener-icoon

2.2.0 by Mobile Technology Lab


Apr 8, 2021

Over Pulmonary Screener

English

Deze mobiele app helpt bij het screenen op verschillende veelvoorkomende longziekten.

This app uses a machine learning algorithm to calculate the relative probability of having certain common pulmonary diseases. The current version of the app can be used to screen for Asthma, COPD, Interstitial Lung Disease (ILD), Allergic Rhinitis, and Respiratory infection. The app was developed as part of a large clinical study, funded by National Institutes of Health, the Tata Trust, and the Vodafone Americas Foundation. This algorithm was originally developed for use in India and was trained using data from over 500 pulmonary patients. NOTE: this app only checks for pulmonary disease and does not provide any information about any other health condition that you may have, such as cardiovascular disease. This app is for informational purposes only and is a screening tool, not a diagnostic tool. It is NOT a replacement for a doctor or a laboratory diagnostic test.

Wat is er nieuw in de nieuwste versie 2.2.0

Last updated on Apr 8, 2021

Now includes screening for: Asthma, COPD, ILD, Allergic Rhinitis, and Respiratory Infection

Added PDF report generation

This release is developed using Flutter cross-platform code

Vertaling Laden...

Aanvullende APP -informatie

Laatste Versie

Verzoek update van Pulmonary Screener 2.2.0

Geüpload door

ธนกฤต นิลศรี

Android vereist

Android 4.4+

Available on

Verkrijg Pulmonary Screener via Google Play

Meer Info

Pulmonary Screener Screenshots

Comment Loading...
Talen
Talen
Aan het zoeken...
Abonneer u op APKPure
Wees de eerste die toegang krijgt tot de vroege release, nieuws en gidsen van de beste Android -games en apps.
Nee bedankt
Aanmelden
Succesvol ingeschreven!
Je bent nu geabonneerd op APKPure.
Abonneer u op APKPure
Wees de eerste die toegang krijgt tot de vroege release, nieuws en gidsen van de beste Android -games en apps.
Nee bedankt
Aanmelden
Succes!
Je bent nu geabonneerd op onze nieuwsbrief.